Yahoo Web Search

  1. Ads
    related to TRD
  1. As part of the expedited program, Axsome said it can file an NDA for the TRD indication — supported by a placebo-controlled Phase 3 trial in TRD — in conjunction with the ongoing ...

  2. Axsome Therapeutics, Inc. (AXSM) Q1 2019 Earnings Call Transcript

    Motley Fool via Yahoo FinanceMay 10 2:59 AM

    I would now like to turn the conference over to your host Mark Jacobson, Senior Vice President of Operations at Axsome Therapeutics. Thank you, Mark.

  3. What's in Store for Axsome (AXSM) This Earnings Season?

    Zacks via Yahoo FinanceMay 07 20:54 PM

    Axsome Therapeutics, Inc. AXSM is scheduled to report first-quarter 2019 earnings results on May 9, 2019, before the market opens. In the last reported quarter, Axsome delivered a positive surprise of 3.03%.

  4. As we head into the weekend, a bit of intriguing news from the biotech world—drug giant Gilead will be donating hundreds of thousands of doses of HIV prevention drugs as part of a deal reached ...

  5. Edited Transcript of LIVN.L earnings conference call or presentation 1-May-19 12:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceMay 03 7:41 AM

    Finally, a Neuromodulation pipeline continues to make good progress in both the treatment-resistant depression, or TRD, and heart failure programs. In TRD, we are making solid ...

  6. Edited Transcript of AXSM earnings conference call or presentation 9-May-19 12:00pm GMT

    Thomson Reuters StreetEvents via Yahoo FinanceMay 10 17:48 PM

    Meaning it is sufficient, along with the ongoing STRIDE-1 Phase 3 in treatment-resistant depression or TRD if positive to support the filing of a new drug application or NDA for approval ...

  1. Ads
    related to TRD